Egrifta WR (tesamorelin F8) is the newest tesamorelin formulation
Inadequate Therapeutic Response: Contact your healthcare provider if you experience minimal or no improvement in target outcomes after reaching your maintenance dose for 12-16 weeks
Identifying additional benefits could help us understand the biological pathways influenced by these drugs and uncover new opportunities for disease prevention and treatment, including cancer prevention. Aparna Kamat, MD Kamat is the senior author of a new study published in the journal Annals of Oncology that found a potential link between taking GLP-1 medications, such as Ozempic , Wegovy , Zepbound , and Mounjaro , and a decrease in the overall risk of developing obesity-related cancers in people without diabetes
Stacking Strategy: Staggered Introduction Start your GLP-1 medication first and establish your baseline response over 2 to 4 weeks
Potential drawbacks to consider: Gastrointestinal stimulation Caffeine increases gastric acid secretion and intestinal motility, which may worsen nausea or diarrhoea in people already experiencing these side effects from Saxenda Sleep disruption Poor sleep quality is associated with weight gain and increased appetite-regulating hormone dysregulation
